Effect of probiotics on symptoms in korean adults with irritable bowel syndrome (Q33446254)

26 July 2017

title

Effect of probiotics on symptoms in korean adults with irritable bowel syndrome (English)

1 reference

26 July 2017

0 references

irritable bowel syndrome

1 reference

Hyoun Woo Kang

2

0 references

Hyun Chae Jung

6

object named as

Hyun Chae Jung

1 reference

26 July 2017

Kyoung Sup Hong

1

1 reference

26 July 2017

Jong Pil Im

3

1 reference

26 July 2017

Geun Eog Ji

4

1 reference

26 July 2017

Sang Gyun Kim

5

1 reference

26 July 2017

In Sung Song

7

1 reference

26 July 2017

Joo Sung Kim

8

1 reference

26 July 2017

publication date

30 June 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

3

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

101-107

1 reference

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Placebo responses in patients with gastrointestinal disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Immune activation in patients with irritable bowel syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

The placebo effect in irritable bowel syndrome trials: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Irritable bowel syndrome in office-based practice in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Epidemiology of colonic symptoms and the irritable bowel syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Defecation frequency and timing, and stool form in the general population: a prospective study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Assessment of lipopolysaccharide-binding activity of Bifidobacterium and its relationship with cell surface hydrophobicity, autoaggregation, and inhibition of interleukin-8 production.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

The RAND 36-Item Health Survey 1.0.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852694

Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20431731

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Activation of the mucosal immune system in irritable bowel syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20431731

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20431731

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.5009/GNL.2009.3.2.101

1 reference

26 July 2017

1 reference

26 July 2017

1 reference